Wholehealth Products, Inc.

GWPC

US96684G1058

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 19:37:07 09/10/2023 BST			5-day change	1st Jan Change
0.0001 ^USD	-.--%		-.--%	-.--%

2014	Wholehealth Products, Inc. Completes Its Phase 2 of the Creation of a Rapid Ebola Test	CI
2014	Wholehealth Products Announces Release of its New Lifesaving Rapid Diagnostic Test, "Rapid Diagnostic Tuberculosis (TB) Whole Blood Test"	CI

Wholehealth Products, Inc. Announces Change of Corporate Headquarter Address

June 09, 2014 at 02:16 pm

Wholehealth Products, Inc. announced that on June 4, 2014, the company relocated its corporate headquarter to 751 South Weir Canyon Road, Suite 157-151, Anaheim, CA 92808.

Latest news about Wholehealth Products, Inc.

Wholehealth Products, Inc. Completes Its Phase 2 of the Creation of a Rapid Ebola Test	14/10/14	CI
Wholehealth Products Announces Release of its New Lifesaving Rapid Diagnostic Test, "Rapid Diagnostic Tuberculosis (TB) Whole Blood Test"	08/10/14	CI
WholeHealth Products Announces the Discovery of the "Autism and Fragile X" Microwell and Rapid Diagnostic Test	30/09/14	CI
WholeHealth Products Announces the Release of the FDA Cleared "Troponin I" Rapid Test	11/09/14	CI
Wholehealth Products, Inc. acquired Rapid Results Corporation.	22/08/14	CI
Wholehealth Products, Inc. Announces Change of Corporate Headquarter Address	09/06/14	CI
Wholehealth Products, Inc. Announces Management Changes	12/12/12	CI
Wholehealth Products, Inc. will Change its Ticker to GWPC from GWPCD	12/10/12	CI
Gulf Western Petroleum Corporation will Change its Name to Wholehealth Products, Inc	17/09/12	CI
Wholehealth Products, Inc. has Changed its Ticker to GWPC.D from GWPC	17/09/12	CI

Chart Wholehealth Products, Inc.

Duration

Period

More charts

Wholehealth Products, Inc. is engaged in the business of developing, manufacturing and marketing in vitro diagnostic (IVD) tests for over-the-counter (OTC or consumer), and point-of-care (POC or professional) use markets. The Company manufactures and markets a range of diagnostic test kits for consumer use through OTC sales, and for use by health care professionals, generally located at medical clinics, physician offices and hospitals known as points-of-care (POC), in the United States.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
WHOLEHEALTH PRODUCTS, INC.	-.--%	51.01K
BIOMÉRIEUX	-3.58%	12.37B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-1.48%	8.37B
DIASORIN S.P.A.	+8.70%	5.84B
LANTHEUS HOLDINGS, INC.	+25.61%	5.4B
AUTOBIO DIAGNOSTICS CO., LTD.	-4.58%	4.37B
10X GENOMICS, INC.	-51.80%	3.23B
ANDON HEALTH CO., LTD.	+16.25%	2.8B
MYRIAD GENETICS, INC.	+30.25%	2.26B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-4.08%	1.87B

Diagnostic & Testing Substances